https://www.avient.com/sites/default/files/2020-07/avient-abac-russian-200721.pdf
2
Подкуп государственных должностных лиц 2
Коммерческий подкуп 3
Платежи за упрощение формальностей и откаты 3
Работа с агентами, дистрибьюторами и иными третьими сторонами 3
Процедура комплексной проверки и процесс одобрения 4
Тревожные признаки 4
Требования к делопроизводству и бухгалтерскому учету 4
Фиксация возможных нарушений 5
Горячая линия по вопросам этики компании Avient 5
Защита от преследований 5
Краткий справочник: ЧТО СЛЕДУЕТ И ЧТО НЕ СЛЕДУЕТ ДЕЛАТЬ СОГЛАСНО АНТИМОНОПОЛЬНЫМ ЗАКОНАМ 6
1
Наша глобальная политика
по борьбе с коррупцией и
взяточничеством
Компания Avient строго запрещает мошенничество,
взяточничество и другие коррупционные практики
при ведении бизнеса в любой точке мира.
Антикоррупционное законодательство запрещает
всем юридическим и физическим лицам предлагать,
обещать, выплачивать или разрешать выплату чего-
2
либо ценного кому-либо2 с целью сохранения или
обеспечения безопасности бизнеса, а также получения
другого ненадлежащего бизнес-преимущества.
К взяткам могут относиться:
• денежные средства и их эквиваленты (подарочные
карты или подарочные сертификаты);
2 Это относится к любому государственному должностному лицу и/или
сотруднику частного сектора
https://www.avient.com/sites/default/files/AVNT Q1 2023 Earnings Press Release.pdf
This was partially driven by composites and sustainable solutions which are
proving to be resilient in a challenging macroeconomic environment and improving our mix of
higher margin applications.”
2
Mr.
Three Months Ended
March 31, 2023
Three Months Ended
March 31, 2022
Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS
Net income from continuing operations attributable to Avient shareholders $ 20.8 $ 0.23 $ 64.4 $ 0.70
Special items, after tax (Attachment 3) 22.3 0.24 6.4 0.07
Amortization expense, after-tax 15.1 0.16 10.8 0.12
Adjusted net income / EPS $ 58.2 $ 0.63 $ 81.6 $ 0.89
8
Attachment 2
Avient Corporation
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
March 31,
2023 2022
Sales $ 845.7 $ 892.2
Cost of sales 598.1 637.8
Gross margin 247.6 254.4
Selling and administrative expense 190.5 152.2
Operating income 57.1 102.2
Interest expense, net (28.8) (16.9)
Other income (expense), net 0.7 (0.6)
Income from continuing operations before income taxes 29.0 84.7
Income tax expense (7.7) (20.0)
Net income from continuing operations 21.3 64.7
(Loss) income from discontinued operations, net of income taxes (0.9) 19.8
Net income 20.4 84.5
Net income attributable to noncontrolling interests (0.5) (0.3)
Net income attributable to Avient common shareholders $ 19.9 $ 84.2
Earnings (loss) per share attributable to Avient common shareholders - Basic:
Continuing operations $ 0.23 $ 0.70
Discontinued operations (0.01) 0.22
Total $ 0.22 $ 0.92
Earnings (loss) per share attributable to Avient common shareholders - Diluted:
Continuing operations $ 0.23 $ 0.70
Discontinued operations (0.01) 0.21
Total $ 0.22 $ 0.91
Cash dividends declared per share of common stock $ 0.2475 $ 0.2375
Weighted-average shares used to compute earnings per common share:
Basic 91.0 91.5
Diluted 91.8 92.3
9
Attachment 3
Avient Corporation
Summary of Special Items (Unaudited)
(In millions, except per share data)
Special items (1) Three Months Ended
March 31,
2023 2022
Cost of sales:
Restructuring costs, including accelerated depreciation $ (6.6) $ (4.4)
Environmental remediation costs (1.4) (2.0)
Reimbursement of previously incurred environmental costs — 0.6
Impact on cost of sales (8.0) (5.8)
Selling and administrative expense:
Restructuring, legal and other (15.7) 1.9
Acquisition related costs (3.4) (2.9)
Impact on selling and administrative expense (19.1) (1.0)
Impact on operating income (27.1) (6.8)
Other income (loss), net (0.2) 0.1
Impact on income from continuing operations before income taxes (27.3) (6.7)
Income tax expense (benefit) on above special items 6.9 1.8
Tax adjustments(2) (1.9) (1.5)
Impact of special items on net income from continuing operations $ (22.3) $ (6.4)
Diluted earnings per common share impact $ (0.24) $ (0.07)
Weighted average shares used to compute adjusted earnings per share:
Diluted 91.8 92.3
(1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt
extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel
reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-
market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation
costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the
divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where
such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring
items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results
2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and changes
to valuation allowances.
10
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
March 31, 2023
December 31,
2022
ASSETS
Current assets:
Cash and cash equivalents $ 582.7 $ 641.1
Accounts receivable, net 484.4 440.6
Inventories, net 371.9 372.7
Other current assets 125.3 115.3
Total current assets 1,564.3 1,569.7
Property, net 1,045.7 1,049.2
Goodwill 1,689.7 1,671.9
Intangible assets, net 1,601.7 1,597.6
Other non-current assets 209.8 196.6
Total assets $ 6,111.2 $ 6,085.0
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term debt $ 2.2 $ 2.2
Accounts payable 448.1 454.4
Accrued expenses and other current liabilities 386.9 412.8
Total current liabilities 837.2 869.4
Non-current liabilities:
Long-term debt 2,177.7 2,176.7
Pension and other post-retirement benefits 66.2 67.2
Deferred income taxes 332.5 342.5
Other non-current liabilities 329.0 276.4
Total non-current liabilities 2,905.4 2,862.8
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,349.8 2,334.5
Noncontrolling interest 18.8 18.3
Total equity 2,368.6 2,352.8
Total liabilities and equity $ 6,111.2 $ 6,085.0
11
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Three Months Ended
March 31,
2023 2022
Operating Activities
Net income $ 20.4 $ 84.5
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 48.7 35.7
Accelerated depreciation 1.8 2.1
Share-based compensation expense 3.2 3.2
Changes in assets and liabilities, net of the effect of acquisitions:
Increase in accounts receivable (40.2) (118.8)
Decrease (increase) in inventories 3.8 (15.1)
(Decrease) increase in accounts payable (9.9) 90.5
Accrued expenses and other assets and liabilities, net (50.0) (63.2)
Net cash (used) provided by operating activities (22.2) 18.9
Investing activities
Capital expenditures (20.3) (13.3)
Net proceeds from divestiture 7.3 —
Net cash used by investing activities (13.0) (13.3)
Financing activities
Purchase of common shares for treasury — (15.8)
Cash dividends paid (22.5) (21.7)
Repayment of long-term debt (0.8) (2.4)
Other financing (2.3) (3.9)
Net cash used by financing activities (25.6) (43.8)
Effect of exchange rate changes on cash 2.4 (0.4)
Decrease in cash and cash equivalents (58.4) (38.6)
Cash and cash equivalents at beginning of year 641.1 601.2
Cash and cash equivalents at end of period $ 582.7 $ 562.6
12
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not
include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments;
intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the
measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
https://www.avient.com/sites/default/files/2020-09/stan-tone-pep-et-product-bulletin.pdf
% Pigment Specific Gravity Color Index Lightfastness
WHITE
10PEP03 Titanium Dioxide, Rutile 60 2.06 PW-6 I/O
YELLOW
12PEP01 Diarylide AAOT GS 20 1.24 PY-14 I
12PEP03 Diarylide HR RS 25 1.23 PY-83 I/O (Mass)
13PEP02 Isoindolinone RS 25 1.31 PY-110 I/O
13PEP03 Benzimidazolone GS 25 1.25 PY-151 I/O (Mass)
81PEP01 Iron Oxide 60 2.07 PY-42 I/O
ORANGE
15PEP03 Benzimidazolone RS 25 1.27 PO-36 I/O
RED
23PEP04 Quinacridone BS 25 1.24 PV-19 I/O
23PEP06 Specialty Naphthol BS 25 1.23 PR-170 I/O (Mass) C
25PEP01 Red 2B, Ca Salt BS 17 1.26 PR-48:2 I/O (Mass)
28PEP01 Red 2B, Ba Salt YS 25 1.32 PR48:1 I/O (Mass)
82PEP01 Iron Oxide, Light YS 27 1.5 PR-101 I/O
82PEP02 Iron Oxide, Light BS 60 2.2 PR-101 I/O
82PEP04 Iron Oxide, Light VYS 60 2.2 PR-101 I/O
82PEP05 Iron Oxide, Dark VBS 60 2.21 PR-101 I/O
BLUE
40PEP01 Phthalocyanine GS 25 1.27 PB-15:3 I/O
40PEP05 Phthalocyanine RS 25 1.27 PB-15 I/O
42PEP02 Ultramarine 35 1.44 PB-29 I/O
49PEP01 Cobalt 31 1.54 PB-28 I/O
GREEN
50PEP01 Phthalocyanine BS 16 1.28 PG-7 I/O
50PEP03 Phthalocyanine YS 16 1.28 PG-7 I/O
59PEP02 Chromium Oxide 70 2.6 PG-17 I/O
VIOLET/MAGENTA
24PEP03 Quinacridone Violet 20 1.24 PV-19 I/O
24PEP04 Ultramarine Violet 50 1.69 PV-15 I/O
24PEP05 Quinacridone Magenta 20 1.24 PR-122 I/O
24PEP06 Benzimidazolone 20 1.23 PV-32 I/O
24PEP07 Carbazole Violet 13 1.22 PV-23 I/O
BROWN/TAN
83PEP01 Iron Oxide, Light 34 1.6 PBr-6 I/O
83PEP02 Iron Oxide, Dark 29 1.51 PBr-6 I/O
BLACK
90PEP01 Furnace - High Jet 24 1.3 PBk-7 I/O
90PEP04 Furnace - Medium 17 1.27 PBk-7 I/O
90PEP05 Iron Oxide 33 1.58 PBk-11 I/O
POLYESTER URETHANE PASTE COLORANTS (PEP)
Stan-Tone Code Pigment Type Approx. % Pigment Specific Gravity Color Index Lightfastness
WHITE
10ET03 Titanium Dioxide, Rutile 56 1.74 PW-6 I/O
YELLOW
12ET01 Diarylide AAOT GS 40 1.15 PY-14 I
12ET03 Diarylide HR RS 20 1.07 PY-83 I/O (Mass)
13ET02 Isoindolinone RS 20 1.11 PY-110 I/O
13ET03 Benzimidazolone GS 20 1.08 PY-151 I/O (Mass)
81ET01 Iron Oxide 60 1.84 PY-42 I/O
ORANGE
15ET03 Benzimidazolone RS 25 1.11 PO-36 I/O
RED
20ET01 Red Lake C YS 30 1.16 PR-53 I
22ET01 Lithol Rubine BS 30 1.17 PR-57:1 I
23ET04 Quinacridone BS 15 1.05 PV-19 I/O
23ET06 Specialty Naphthol BS 30 1.09 PR-170 I/O (Mass) C
25ET01 Red 2B, Ca Salt BS 29 1.15 PR-48:2 I/O (Mass)
28ET01 Red 2B, Ba Salt YS 30 1.18 PR-48:1 I/O (Mass)
82ET01 Iron Oxide, Light BS 60 1.94 PR-101 I/O
82ET02 Iron Oxide, Dark VBS 60 1.95 PR-101 I/O
82ET04 Iron Oxide, Light VYS 60 1.94 PR-101 I/O
BLUE
40ET01 Phthalocyanine GS 25 1.11 PB-15:3 I/O
40ET05 Phthalocyanine RS 20 1.09 PB-15 I/O
42ET02 Ultramarine 55 1.46 PB-29 I/O
49ET01 Cobalt 65 2.02 PB-28 I/O
GREEN
50ET01 Phthalocyanine BS 30 1.2 PG-7 I/O
50ET03 Phthalocyanine YS 25 1.16 PG-7 I/O
59ET01 Chromium Oxide 65 2.12 PG-17 I/O
VIOLET/MAGENTA
24ET03 Quinacridone Violet 20 1.08 PV-19 I/O
24ET04 Ultramarine Violet 60 1.66 PV-15 I/O
24ET05 Quinacridone Magenta 20 1.08 PR-122 I/O
24ET06 Benzimidazolone 25 1.08 PV-32 I/O
24ET07 Carbazole Violet 13 1.05 PV-23 I/O
BROWN/TAN
83ET01 Iron Oxide, Light 64 2.02 PBr-6 I/O
83ET02 Iron Oxide, Dark 60 1.9 PBr-6 I/O
BLACK
90ET04 Furnace - Medium 22 1.12 PBk-7 I/O
90ET05 Iron Oxide 60 1.9 PBk-11 I/O
POLYETHER URETHANE PASTE COLORANTS (ET)
PEP/ET
RS = Red Shade
YS = Yellow Shade
VYS = Very Yellow Shade
BS = Blue Shade
VBS = Very Blue Shade
GS = Green Shade
HR = Heat-Resistant
LIGHTFASTNESS
I = Indoor Only
I/O = Indoor or Outdoor
Mass = Outdoor Masstone Application Only
C = Some Caution Advised
www.avient.com
Copyright © 2020, Avient Corporation.
